SweeGen receives GRAS no objection letter from FDA for its Bestevia Reb E

June 25, 2019

SweeGen, Inc.'s proprietary Rebaudioside E is now Generally Recognized as Safe (GRAS) after FDA issues no objection letter. 

SweeGen, Inc. (Rancho Santa Margarita, CA), a stevia-based sweetener company, announced that FDA issued a GRAS (Generally Recognized As Safe) No Objection Letter for Bestevia Rebaudioside E (Reb E) stevia leaf sweetener for use in foods. Used in SweeGen’s Bestevia e+ ingredient, Bestevia Reb E is produced from the stevia leaf through a non-GMO bioconversion process, and it can be used in a variety of applications, including beverage, dairy, sports nutrition, condiments, and bakery.

"Reb E is one of the main components in our Bestevia e+. It was specifically created for alcoholic and non-alcoholic beverages in response to concerns from some regarding application IP for Reb M in beverages," said Shari Joslin, vice president of application technology for SweeGen, in a press release. "BESTEVIA e+ provides a mouthfeel and taste closest to sugar."

"Bestevia e+ provides a clean, sugar-like taste at a price equivalent to sugar. In addition to the success we have with our non-GMO Bestevia Reb M and Reb D, we are excited to add Bestevia e+ to our sweetener portfolio," added Katharina Pueller, director natural sweetener business.